JYOTHY LABS LIMITED
Jyothy Labs Limited, together with its subsidiaries, manufactures and markets fabric care, dishwashing, personal care, and household insecticides products in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, and Others segments. The Dishwashing segment offers dish wash bars, gels, and liquids, as well as dish wash scrubbers, steel scrubbers, and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, enhancers, and conditioner; detergent powders; and detergent liquids and bar soaps under the Henko, Mr. White, Ujala, and More light brands. The Household Insecticides segment offers mosquito repellent coils, aerosol, liquids, and racquet, as well as surface cleaners and air care products under the Maya, T- Shine, and Maxo brands. The Personal Care segment provides body soaps, toothpastes, deodorants, talcum powders, after shave products, and hand washes under the Margo, FA, and Neem Active brands. The Others segment offers incense sticks under the Maya brand; and toilet and floor cleaner products. The company also provides dry cleaning and laundry services under the Fabric Spa brand. The company was formerly known as Jyothy Laboratories Limited and changed its name to Jyothy Labs Limited in July 2019. Jyothy Labs Limited was founded in 1983 and is based in Mumbai, India.
Valuation
Profitability
Returns
Solvency
AI Summary
Indian StockStrengths1
- Strong 5-year net profit CAGR of 18.6%
Concerns1
- Negative free cash flow (βΉ7 Cr)
Rule-based from financial data. Not advice.
Monthly Returns
Year-to-Date ROI
Historical Volatility
Historical Performance
Revenue, profitability, and cash flow trends (βΉ Crores)
Revenue (10Y)
Operating Income (10Y)
Net Profit (10Y)
Operating Margin % (10Y)
Dividend Payout % (10Y)
Free Cash Flow (10Y)
Growth Summary
Latest fiscal year: Mar 2025
Historical Growth
Year-by-year revenue, profitability, and cash flow (βΉ Crores, last 10 years)
| Year | Revenue | Op. Income | Net Profit | CFO | FCF | ROE | Rev Growth 1Y | NP Growth 1Y |
|---|---|---|---|---|---|---|---|---|
| Mar 2025 | βΉ2.84 K Cr | β | βΉ371.00 Cr | β | β | 26.8% | 3.3% | 0.3% |
| Mar 2024 | βΉ2.75 K Cr | β | βΉ370.00 Cr | β | β | 32.4% | 11.0% | 54.2% |
| Mar 2023 | βΉ2.48 K Cr | β | βΉ240.00 Cr | β | β | 27.2% | 13.2% | 72.7% |
| Mar 2022 | βΉ2.19 K Cr | β | βΉ139.00 Cr | β | β | 19.0% | 16.3% | -26.8% |
| Mar 2021 | βΉ1.89 K Cr | β | βΉ190.00 Cr | β | β | 20.3% | 13.2% | 20.3% |
| Mar 2020 | βΉ1.67 K Cr | β | βΉ158.00 Cr | β | β | 21.2% | -5.9% | -18.1% |
| Mar 2019 | βΉ1.77 K Cr | β | βΉ193.00 Cr | β | β | 22.6% | 8.8% | 19.9% |
| Mar 2018 | βΉ1.63 K Cr | β | βΉ161.00 Cr | β | β | 23.6% | -0.4% | -20.3% |
| Mar 2017 | βΉ1.63 K Cr | β | βΉ202.00 Cr | β | β | 30.9% | 5.8% | 169.3% |
| Mar 2016 | βΉ1.54 K Cr | β | βΉ75.00 Cr | β | β | 15.9% | 7.2% | -47.6% |
Financial Statements
Income statement, balance sheet, and cash flow (βΉ Crores, as reported)
Consolidated Figures in USD Millions.
| Unnamed: 0 | TTM |
|---|---|
| Revenue / Net Sales | 2,857 |
| Total Expenses | 2,387 |
| EBIT / Operating Profit | 470 |
| OPM % | 16% |
| Other Income | 62 |
| Finance Costs | 6 |
| Depreciation & Amortisation | 59 |
| Profit Before Tax | 468 |
| Tax % | - |
| Net Profit / PAT | 349 |
| EPS (βΉ) | 9.51 |
| Dividend Payout % | - |
Peer Comparison
Healthcare sector peers, ranked by market cap
| Company | Market Cap | Revenue | P/E | P/B | EV/EBITDA | Rev G 1Y |
|---|---|---|---|---|---|---|
| JYOTHY LABS LIMITEDthis co. | βΉ9.55 K Cr | βΉ2.84 K Cr | 27.20 | 6.63 | 17.59 | 3.3% |
| Sun Pharmaceutical Industries Ltd. | βΉ4.15 L Cr | βΉ23.00 K Cr | 88.70 | 17.43 | 72.30 | 13.5% |
| Divi's Laboratories Ltd. | βΉ1.71 L Cr | βΉ9.20 K Cr | 67.90 | 11.13 | 67.21 | 20.0% |
| Torrent Pharmaceuticals Ltd. | βΉ1.33 L Cr | βΉ9.68 K Cr | 62.50 | 15.76 | 45.64 | 13.5% |
| Cipla Ltd. | βΉ1.17 L Cr | βΉ19.05 K Cr | 22.50 | 3.51 | 19.33 | 14.9% |
| Apollo Hospitals Enterprises Ltd. | βΉ1.05 L Cr | βΉ8.20 K Cr | 75.00 | 11.28 | 54.44 | 12.8% |
| Max Healthcare Institute Limited | βΉ1.00 L Cr | βΉ2.66 K Cr | 144.00 | 11.76 | 96.84 | 13.8% |
| Industry Average | β | βΉ3.29 K Cr | 98.63 | 8.11 | 65.50 | 20.2% |